You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and updated drug and regimen monographs, patient information sheets, as well as safety and advice documents added to the Drug Formulary within the last 30 days are available here.

Drug

Published Date: 19 Mar 2020

Revision Summary: edited indications
Updated
Mar 2020
Regimen

Published Date: 17 Mar 2020

Revision Summary: Added rituximab NDFP forms and interchangeability information in Drug Regimen and Drug Administration and Special Precautions sections
Updated
Mar 2020
Drug

Published Date: 17 Mar 2020

Revision Summary: Updated emetic risk category
Updated
Mar 2020
Regimen

Published Date: 17 Mar 2020

Revision Summary: Added rituximab (IV and subcut) NDFP forms and rituximab (subcut) option
Updated
Mar 2020
Drug

Published Date: 17 Mar 2020

Revision Summary: Updated NDFP forms and interchangeability information in Dosing and Administration sections
Updated
Mar 2020
Regimen

Published Date: 16 Mar 2020

Revision Summary: Added gastric cancer as an ST-QBP approved indication.
Updated
Mar 2020
Regimen

Published Date: 16 Mar 2020

Revision Summary: New ST-QBP regimen
New
Mar 2020
Regimen

Published Date: 16 Mar 2020

Revision Summary: New ST-QBP regimen
New
Mar 2020
Regimen

Published Date: 16 Mar 2020

Revision Summary: Removed subcut alternative schedule since new ST-QBP regimen CYTA(SC) has been added.
Updated
Mar 2020
Regimen

Published Date: 16 Mar 2020

Revision Summary: New ST-QBP regimen
New
Mar 2020
Regimen

Published Date: 16 Mar 2020

Revision Summary: New ST-QBP regimen
New
Mar 2020
Drug

Published Date: 16 Mar 2020

Revision Summary: Updated infusion reaction information in Adverse Effects, Dosing and Administration sections.
Updated
Mar 2020